228 related articles for article (PubMed ID: 16511381)
21. Effects of amoxicillin and cefdinir on nasopharyngeal bacterial flora.
Brook I; Gober AE
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):785-7. PubMed ID: 16172355
[TBL] [Abstract][Full Text] [Related]
22. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.
Gehanno P; Lenoir G; Berche P
Antimicrob Agents Chemother; 1995 Jan; 39(1):271-2. PubMed ID: 7695322
[TBL] [Abstract][Full Text] [Related]
23. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
Sader HS; Jones RN
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
[TBL] [Abstract][Full Text] [Related]
24. Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.
Hatakka K; Blomgren K; Pohjavuori S; Kaijalainen T; Poussa T; Leinonen M; Korpela R; Pitkäranta A
Clin Nutr; 2007 Jun; 26(3):314-21. PubMed ID: 17353072
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and treatment of otitis media.
Ramakrishnan K; Sparks RA; Berryhill WE
Am Fam Physician; 2007 Dec; 76(11):1650-8. PubMed ID: 18092706
[TBL] [Abstract][Full Text] [Related]
26. Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan.
Hotomi M; Billal DS; Kamide Y; Kanesada K; Uno Y; Kudo F; Ito M; Kakehata S; Sugita R; Ogami M; Yamanaka N;
J Clin Microbiol; 2008 Nov; 46(11):3808-10. PubMed ID: 18832131
[TBL] [Abstract][Full Text] [Related]
27. Impact of amoxicillin on pneumococcal colonization compared with other therapies for acute otitis media.
Toltzis P; Dul M; O'Riordan MA; Toltzis H; Blumer JL
Pediatr Infect Dis J; 2005 Jan; 24(1):24-8. PubMed ID: 15665706
[TBL] [Abstract][Full Text] [Related]
28. [Infections with drug resistant bacteria and their treatment methods--PRSP infections].
Kuroki H
Rinsho Byori; 2000 Jan; Suppl 111():125-31. PubMed ID: 10804802
[TBL] [Abstract][Full Text] [Related]
29. Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?
Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2006 Aug; 55(4):351-6. PubMed ID: 16765555
[TBL] [Abstract][Full Text] [Related]
30. A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
Brook I
Clin Ther; 2005 Aug; 27(8):1266-73. PubMed ID: 16199251
[TBL] [Abstract][Full Text] [Related]
31. Failure of a 5-day course of intramuscular ceftriaxone to eradicate Streptococcus pneumoniae from the middle ear.
Anon JB; Ripple WL; Jacobs MR
Pediatr Infect Dis J; 2006 Feb; 25(2):181-2. PubMed ID: 16462302
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and pharmacodynamics of gatifloxacin in children with recurrent otitis media: application of sparse sampling in clinical development.
Rubino CM; Ambrose P; Cirincione B; Arguedas A; Sher L; Lopez E; Sáez-Llorens X; Grasela DM
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):67-74. PubMed ID: 17875453
[TBL] [Abstract][Full Text] [Related]
33. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Sader HS; Jacobs MR; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
[TBL] [Abstract][Full Text] [Related]
34. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
[TBL] [Abstract][Full Text] [Related]
35. Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.
París MM; Devcich KJ
Cutis; 2004 May; 73(5 Suppl):14-8. PubMed ID: 15182160
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of acute otitis media caused by Streptococcus pneumoniae: emergence of serotype 19A].
Mahjoub-Messai F; Doit C; Mariani-Kurkdjian P; François M; Bingen E
Arch Pediatr; 2008 Nov; 15(11):1713-6. PubMed ID: 18926673
[TBL] [Abstract][Full Text] [Related]
37. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis.
Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
Pediatr Infect Dis J; 2006 Jul; 25(7):602-7. PubMed ID: 16804429
[TBL] [Abstract][Full Text] [Related]
38. Penicillin susceptibility of pneumococcal isolates causing acute otitis media in children: seasonal variation.
Hoberman A; Paradise JL; Greenberg DP; Wald ER; Kearney DH; Colborn DK
Pediatr Infect Dis J; 2005 Feb; 24(2):115-20. PubMed ID: 15702038
[TBL] [Abstract][Full Text] [Related]
39. Resisting the urge to prescribe.
Edwards KM
J Pediatr; 1996 Jun; 128(6):729-30. PubMed ID: 8648528
[No Abstract] [Full Text] [Related]
40. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
Dagan R
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
